CN102940706A - Traditional Chinese medicine composition for treating fundus hemorrhage - Google Patents
Traditional Chinese medicine composition for treating fundus hemorrhage Download PDFInfo
- Publication number
- CN102940706A CN102940706A CN2012103472575A CN201210347257A CN102940706A CN 102940706 A CN102940706 A CN 102940706A CN 2012103472575 A CN2012103472575 A CN 2012103472575A CN 201210347257 A CN201210347257 A CN 201210347257A CN 102940706 A CN102940706 A CN 102940706A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating fundus hemorrhage. The medicine is composed of the following Chinese medicinal materials, by weight: 5-20 parts of pseudo-ginseng, 5-20 parts of root of balloonflower, 5-20 parts of root of balloonflower, 5-20 parts of Astragalus, 5-20 parts of Polygonum cuspidatum, 10-30 parts of red-rooted salvia, 5-20 parts of Ligusticum wallichii, 5-20 parts of motherwort, 5-20 parts of chrysanthemum, 5-20 parts of safflower and 5-20 parts of peach kernel. The Chinese medicine composition provided by the invention has the effects of clearing heat, calming wind, stopping bleeding and pain, invigorating circulation of blood, scattering stasis, tonifying lung, strengthening spleen, nourishing liver and improving eyesight, obvious curative effect on fundus hemorrhage and reliable function; and the components have wide medicinal sources, simple preparation and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicinal preparation of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of retinal hemorrhage.
Background technology
We know, retinal hemorrhage is the common a kind of clinical symptoms of ophthalmology, and it is not a kind of independently oculopathy, but a lot of oculopathy and the common disease of some hologathy.Retinal hemorrhage is because the cause of disease is complicated, so the course of disease is long, easily repeatedly outbreak has a strong impact on vision, causes many serious complication.Such as maculopathy (cystoid macular edema, degeneration of macula), neovascular glaucoma, vitreous hemorrhage, optic atrophy, proliferative retinopathy, tractional detachment of retina such as untimely effective treatment, often can cause losing one's sight.At present, doctor trained in Western medicine mainly adopts laser therapy to the treatment of retinal hemorrhage, the treatment of the methods such as cellosolve, anti-platelet aggregation agent.Certain effect is arranged clinically, and these can be treated can only be to the new vessels that existed and the control state of an illness, but can not stop the formation of new new vessels.In addition, to the further absorption of blood stasis, recover vision, the outbreak of prevention Relapse rate, effect is undesirable.
Motherland's medical science is thought, because of the objective lung meridian of heat, lung-QI being unable to descend, bleeding due to blood-heat; Worn with age, the heart-nutriment consume, deficiency of the liver and kindey makes venation lose profit, is easy to break and outside the blood oozing from the body openings or subcuta neous tissue network; Acutely choke and cough, vomit, cause the QI rising in reverse order upper punch, indulging in excessive drinking smokes on excessive and damp and hot; The factors such as women's vicarious menstruation, eye wound, the breakage of order network cause escape of blood from meridians, overflow outside the arteries and veins.
For the pathogeny of retinal hemorrhage, take stop blooding, invigorate blood circulation, dissipating blood stasis is as the rule for the treatment of, carries out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the prior art doctor trained in Western medicine deficiency undesirable to the retinal hemorrhage therapeutic effect, the invention provides a kind ofly prepare conveniently, the medicine source is wide, cost is low, the Chinese medicine composition of evident in efficacy, reliable effect, the treatment retinal hemorrhage that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of retinal hemorrhage is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 5～20 parts of Radix Notoginseng, 5～20 parts of Radix Platycodoniss, 5～20 parts of Pheretimas, 5～20 parts of the Radixs Astragali, 5～20 parts of Rhizoma Polygoni Cuspidati, 10～30 parts of Radix Salviae Miltiorrhizaes, 5～20 parts of Rhizoma Chuanxiongs, 5～20 parts of Herba Leonuris, 5～20 parts of Flos Chrysanthemis, 5～20 parts on Flos Carthami, 5～20 parts in Semen Persicae.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of retinal hemorrhage is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10 parts of Radix Notoginseng, 15 parts of Radix Platycodoniss, 10 parts of Pheretimas, 12 parts of the Radixs Astragali, 10 parts of Rhizoma Polygoni Cuspidati, 20 parts of Radix Salviae Miltiorrhizaes, 12 parts of Rhizoma Chuanxiongs, 10 parts of Herba Leonuris, 15 parts of Flos Chrysanthemis, 10 parts on Flos Carthami, 15 parts in Semen Persicae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: Radix Notoginseng has the effect of activating blood and removing stasis, hemostasis, reducing swelling and alleviating pain; Radix Platycodonis has lung qi dispersing and eliminates the phlegm, fosters the spirit of nobility and enrich blood, sharp the five internal organs, mend the effect of five kinds of over strain; Pheretima has the effect of clearing heat for calming endogenous wind, lung-clearing asthma-relieving, inducing diuresis for treating stranguria syndrome, current meridians; The Radix Astragali has that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating take off admittedly, the effect of wind dispelling fortune poison; Rhizoma Polygoni Cuspidati has the effect of promoting blood circulation to remove blood stasis, dispelling wind and removing obstruction in the collateral, clearing away heat-damp and promoting diuresis, detoxifcation; Radix Salviae Miltiorrhizae has the effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Rhizoma Chuanxiong has the effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Herba Leonuri has promoting blood flow to regulate menstruation, the effect of inducing diuresis to remove edema; Flos Chrysanthemi has that dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, the effect of heat-clearing and toxic substances removing; Flos Carthami has the effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Semen Persicae has the effect of blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays altogether the effect of clearing heat for calming endogenous wind, hemostasis and pain-relieving, promoting blood circulation to remove blood stasis, tonifying the lung spleen invigorating, nourishing the liver to improve visual acuity, retinal hemorrhage reached the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, toxic and side effects do not occur, total effective rate 90.9%, cure rate reaches 65.9%.
The specific embodiment
The present invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of retinal hemorrhage, its raw material of Chinese medicine by following weight proportion forms: Radix Notoginseng 10g, Radix Platycodonis 15g, Pheretima 10g, Radix Astragali 12g, Rhizoma Polygoni Cuspidati 10g, Radix Salviae Miltiorrhizae 20g, Rhizoma Chuanxiong 12g, Herba Leonuri 10g, Flos Chrysanthemi 15g, Flos Carthami 10g, Semen Persicae 15g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of retinal hemorrhage, its raw material of Chinese medicine by following weight proportion forms: Radix Notoginseng 15g, Radix Platycodonis 10g, Pheretima 5g, Radix Astragali 20g, Rhizoma Polygoni Cuspidati 5g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 20g, Herba Leonuri 15g, Flos Chrysanthemi 10g, Flos Carthami 8g, Semen Persicae 5g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of retinal hemorrhage, its raw material of Chinese medicine by following weight proportion forms: Radix Notoginseng 20g, Radix Platycodonis 12g, Pheretima 12g, Radix Astragali 5g, Rhizoma Polygoni Cuspidati 8g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 20g, Herba Leonuri 15g, Flos Chrysanthemi 10g, Flos Carthami 8g, Semen Persicae 5g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of retinal hemorrhage, its raw material of Chinese medicine by following weight proportion forms: Radix Notoginseng 5g, Radix Platycodonis 20g, Pheretima 15g, Radix Astragali 10g, Rhizoma Polygoni Cuspidati 20g, Radix Salviae Miltiorrhizae 15g, Rhizoma Chuanxiong 15g, Herba Leonuri 5g, Flos Chrysanthemi 20g, Flos Carthami 5g, Semen Persicae 8g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of retinal hemorrhage, its raw material of Chinese medicine by following weight proportion forms: Radix Notoginseng 12g, Radix Platycodonis 5g, Pheretima 20g, Radix Astragali 15g, Rhizoma Polygoni Cuspidati 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Chuanxiong 10g, Herba Leonuri 12g, Flos Chrysanthemi 5g, Flos Carthami 20g, Semen Persicae 10g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have approximately 8 centimetres of powder, carry out decocting the first time, at a simmer the front intense fire that adopts decocts, and boils rear with slow fire boiling 20～30 minutes; When decocting for the second time, add water and do not have approximately 6 centimetres of powder, the water rear decoction 15～20 minutes of boiling.Twice decoction extracting juice that removes slag merges.
A kind of Chinese medicine composition for the treatment of retinal hemorrhage, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to observe case 44 examples, male 24 examples wherein, women 20 examples, 16～70 years old age.The course of disease 5～15 days.
Two, diagnostic criteria: with reference to the diagnostic criteria of (1) sudden blindness in " traditional Chinese medical science disease Standardization of diagnosis and curative effect " of State Administration of Traditional Chinese Medicine's promulgation in 1994; (2) diagnostic criteria of blurring of vission; (3) cloud and mist moves fine diagnostic criteria; (4) diagnostic criteria of hyphema and vitreous hemorrhage.
Three, usage and dosage: during clinical practice, the amounts of components in the compositions is taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Seven days is a course for the treatment of, one day potion, and twice extracting juice of decocting be 400ml approximately, minute morning, late warm taking.
Four, efficacy evaluation:
(1) recovery from illness: retinal hemorrhage all absorbs, and vision significantly improves more than 5 row or recovers previous level, underwent eye-ground vascular fluorescence visualization retinal circulation condition improvement;
(2) produce effects: retinal hemorrhage is most of to be absorbed, and vision improves 3～5 row, and underwent eye-ground vascular fluorescence visualization retinal circulation state partly improves;
(3) take a turn for the better: retinal hemorrhage partially absorbs, and vision improves 1～2 row, and underwent eye-ground vascular fluorescence visualization retinal circulation state makes moderate progress;
(4) invalid: retinal hemorrhage absorbs not obvious, and vision is without obviously improving or go down, and fluorescence fundus angiography retinal circulation state is without obvious improvement, or has complication to occur.
Five, therapeutic effect: in this clinical observation case, take medicine 1～10 course for the treatment of, cure 29 examples, produce effects 6 examples, 5 examples that take a turn for the better, invalid 4 examples.Toxic and side effects does not occur during the treatment.
Six, model case:
Case 1:
Dong, man, 32 years old.Medical front 5 days, the left eye blurring of vision appears without obvious cause, and right eye is without discomfort.Have an eyesight test: right eye 5.1, left eye 4.7, two outer emmetropia, the right eye optical fundus is without unusually.A small amount of cotton-shaped hematocele is arranged in the left eye vitreous body, still can see the optical fundus, depending on the nipple sharpness of border, retina temporo lateral vein Zhi Youbai sheath adheres to, and its downside is seen 1PD cerise ecchymosis, and central fovea of macula is reflective to may be seen indistinctly.Be diagnosed as hemorrhage (left blurring of vission) at the bottom of the left eye.Take 1 course for the treatment of of medicament of Chinese medicine composition preparation of the present invention, stable disease, vision is increased to 4.9, continues to take 2 courses for the treatment of, and vision is raised to 5.0, and retinal hemorrhage all absorbs, and vitreous body is without obvious muddiness; For consolidating curative effect, continue to take 3 days after, do not follow up a case by regular visits to again recurrence.
Case 2:
Blue certain, man, 35 years old.Left eye blurring of vision 2 months has an eyesight test: right eye 5.2, left eye 4.3.Optical fundus: left eye optic disc obscure boundary, be the large tracts of land flame-shaped hemorrhage on every side, the tortuous anger of retinal vein is opened, and the disappearance of macular area reflective spot is diagnosed as: left eye retinal hemorrhage (hyphema and vitreous hemorrhage disease), take 5 courses for the treatment of of medicament of Chinese medicine composition preparation of the present invention, vision: right eye 5.2, left eye 4.9, retinal hemorrhage absorbs at the bottom of the left eye, produce effects is left hospital, and follows up a case by regular visits to not again recurrence.
Claims (2)
1. Chinese medicine composition for the treatment of retinal hemorrhage, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 5～20 parts of Radix Notoginseng, 5～20 parts of Radix Platycodoniss, 5～20 parts of Pheretimas, 5～20 parts of the Radixs Astragali, 5～20 parts of Rhizoma Polygoni Cuspidati, 10～30 parts of Radix Salviae Miltiorrhizaes, 5～20 parts of Rhizoma Chuanxiongs, 5～20 parts of Herba Leonuris, 5～20 parts of Flos Chrysanthemis, 5～20 parts on Flos Carthami, 5～20 parts in Semen Persicae.
2. a kind of Chinese medicine composition for the treatment of retinal hemorrhage according to claim 1, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10 parts of Radix Notoginseng, 15 parts of Radix Platycodoniss, 10 parts of Pheretimas, 12 parts of the Radixs Astragali, 10 parts of Rhizoma Polygoni Cuspidati, 20 parts of Radix Salviae Miltiorrhizaes, 12 parts of Rhizoma Chuanxiongs, 10 parts of Herba Leonuris, 15 parts of Flos Chrysanthemis, 10 parts on Flos Carthami, 15 parts in Semen Persicae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103472575A CN102940706A (en) | 2012-09-19 | 2012-09-19 | Traditional Chinese medicine composition for treating fundus hemorrhage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103472575A CN102940706A (en) | 2012-09-19 | 2012-09-19 | Traditional Chinese medicine composition for treating fundus hemorrhage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102940706A true CN102940706A (en) | 2013-02-27 |
Family
ID=47723766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103472575A Pending CN102940706A (en) | 2012-09-19 | 2012-09-19 | Traditional Chinese medicine composition for treating fundus hemorrhage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940706A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112336833A (en) * | 2020-06-15 | 2021-02-09 | 周燕英 | A Chinese medicinal composition for treating hemorrhagic eye diseases, and its preparation method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101966226A (en) * | 2010-10-08 | 2011-02-09 | 张继成 | Chinese medicinal composition for treating heart cerebrovascular diseases |
| KR20110054579A (en) * | 2009-11-18 | 2011-05-25 | 강홍구 | Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery |
| US20120071431A1 (en) * | 2010-03-29 | 2012-03-22 | Greenway Frank L | Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis |
| CN102512521A (en) * | 2011-12-16 | 2012-06-27 | 商洛学院 | Traditional Chinese medicine composition for treating apoplexy sequela |
-
2012
- 2012-09-19 CN CN2012103472575A patent/CN102940706A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110054579A (en) * | 2009-11-18 | 2011-05-25 | 강홍구 | Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery |
| US20120071431A1 (en) * | 2010-03-29 | 2012-03-22 | Greenway Frank L | Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis |
| CN101966226A (en) * | 2010-10-08 | 2011-02-09 | 张继成 | Chinese medicinal composition for treating heart cerebrovascular diseases |
| CN102512521A (en) * | 2011-12-16 | 2012-06-27 | 商洛学院 | Traditional Chinese medicine composition for treating apoplexy sequela |
Non-Patent Citations (1)
| Title |
|---|
| 李新华等: "活血化瘀治疗视网膜静脉阻塞", 《中国眼耳鼻喉科杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112336833A (en) * | 2020-06-15 | 2021-02-09 | 周燕英 | A Chinese medicinal composition for treating hemorrhagic eye diseases, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550532B (en) | Traditional Chinese medicine (TCM) composition for treating palpitation | |
| CN102600386B (en) | Chinese herba preparation for treating eye inflammation and preparation method of Chinese herba preparation | |
| CN105168984A (en) | Chinese herbal compound eye plaster for treating ophthalmic diseases | |
| CN105288208A (en) | Traditional Chinese medicine composition for treating acute optic neuritis | |
| CN102973842B (en) | Traditional Chinese medicine fuming and washing liquid for treating xerophthalmia | |
| CN103961626A (en) | Chinese herbal medicine pill for treating fundus hemorrhage | |
| CN104606635A (en) | Traditional Chinese medicine composition for treating retinal vein obstruction | |
| CN105267674A (en) | Traditional Chinese medicine composition for treating acute mastitis | |
| CN104587257A (en) | Traditional Chinese medicine composition for treating diabetic macular edema | |
| CN102389488A (en) | Traditional Chinese medicine for curing diabetic retinopathy | |
| CN102940706A (en) | Traditional Chinese medicine composition for treating fundus hemorrhage | |
| CN103830552A (en) | Traditional Chinese medicine composition for treating Meniere's disease | |
| CN102379967A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
| CN102716212B (en) | Medicine for treating cerebral infarction | |
| CN102389484A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
| CN114452365B (en) | Traditional Chinese medicine preparation for treating chalazion | |
| CN102018830A (en) | Traditional Chinese medicine for treating fundus hemorrhage | |
| CN102091212B (en) | Traditional Chinese medicine decoction for treating recurrent central serous chorioretinopathy | |
| CN102389485A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
| CN104873668A (en) | Traditional Chinese medicine composition for treating optic atrophy | |
| CN104645071A (en) | Medicine for treating kidney yin deficiency type diabetic retinopathy and preparation method thereof | |
| CN104288604A (en) | Traditional Chinese medicine composition for treating cerebral infarction | |
| CN104524036A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method thereof | |
| CN103610797A (en) | Traditional Chinese medicine composition for treating keratoconjunctivitis due to congestion and excess of dampness-heat | |
| CN102940769B (en) | Traditional Chinese medicine composition for treating vertigo caused by cerebral blood deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130227 |